Scaramucci raises $100 million to invest in Algorand (ALGO) fund

Earlier this week, the Anthony Scaramucci-owned SkyBridge Capital announced at its annual SALT Conference that it had filed an application for a crypto-related exchange-traded fund (ETF) to expand its offerings.

This did not come alone, as the announcement also contained the plan to start an Algorand fund capped at $250 million.

To read the rest of this article, sign in or join CryptoSlate Edge.

CryptoSlate Edge helps you understand the cryptoasset market more clearly.

We can all agree that the crypto market is fast-moving and confusing, but CryptoSlate Edge can help make sense of it for you.

Enhanced news coverage

Exclusive articles and insights

Get an analytical edge by accessing members-only articles with curated insights from crypto analysts around the globe.
Real-time charts and price snapshots

Gain a better understanding of the market with real-time charts, price snapshots and more market data in every news article.
Explore the companies, products and people in our articles

We display profiles of people, companies, products, and assets related to every Edge article so you can connect the dots.

Extensive crypto asset and sector data

On-chain metrics and social sentiment

Gain a better understanding of the on-chain trends an explore social sentiment for individual crypto assets.
Crypto asset transaction demographics

Understand where the majority of crypto asset transactions are taking place globally.
Explore innovative projects and sectors

Follow new projects and crypto sectors with our manually curated data for over 50 industry verticals.

What else?

Private Telegram community

As an Edge subscriber, you will access new articles first and engage with the community in our private Telegram channel.
A clean, ad-free experience

We hide all advertisements for CryptoSlate Edge subscribers.
Support independent journalism

As an independent organization in the blockchain industry, we are guided by a strict editorial policy that emphasizes objectivity and transparency in our coverage.